Literature DB >> 28410852

Cefiderocol MIC quality control ranges in iron-depleted cation-adjusted Mueller-Hinton broth using a CLSI M23-A4 multi-laboratory study design.

Michael D Huband1, Akinobu Ito2, Masakatsu Tsuji2, Helio S Sader3, Kelley A Fedler3, Robert K Flamm3.   

Abstract

Cefiderocol (formerly S-649266) is a new catechol-substituted parenteral siderophore cephalosporin with potent in vitro antibacterial activity against Gram-negative isolates including multidrug-resistant strains. A recent study following CLSI M23-A4 quality control guidelines established cefiderocol MIC QC ranges against Escherichia coli ATCC 25922 (0.06-0.5 μg/mL) and Pseudomonas aeruginosa ATCC 27853 (0.06-0.5 μg/mL).
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cefiderocol; M23; Quality control; S-649266; Siderophore cephalosporin

Mesh：

Substances：

Year:  2017        PMID： 28410852     DOI： 10.1016/j.diagmicrobio.2017.03.011

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  11 in total

1.  Burkholderia pseudomallei Clinical Isolates Are Highly Susceptible In Vitro to Cefiderocol, a Siderophore Cephalosporin.

Authors:  Delaney Burnard; Gemma Robertson; Andrew Henderson; Caitlin Falconer; Michelle J Bauer; Kyra Cottrell; Ian Gassiep; Robert Norton; David L Paterson; Patrick N A Harris
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

2.  ARGONAUT-I: Activity of Cefiderocol (S-649266), a Siderophore Cephalosporin, against Gram-Negative Bacteria, Including Carbapenem-Resistant Nonfermenters and Enterobacteriaceae with Defined Extended-Spectrum β-Lactamases and Carbapenemases.

Authors:  Michael R Jacobs; Ayman M Abdelhamed; Caryn E Good; Daniel D Rhoads; Kristine M Hujer; Andrea M Hujer; T Nicholas Domitrovic; Susan D Rudin; Sandra S Richter; David van Duin; Barry N Kreiswirth; Chris Greco; Derrick E Fouts; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

3.  Activity of the novel siderophore cephalosporin cefiderocol against multidrug-resistant Gram-negative pathogens.

Authors:  J Dobias; V Dénervaud-Tendon; L Poirel; P Nordmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-07-26       Impact factor: 3.267

Review 4.  Iron Acquisition Mechanisms and Their Role in the Virulence of Acinetobacter baumannii.

Authors:  Shoshana Cook-Libin; Ellen M E Sykes; Vanessa Kornelsen; Ayush Kumar
Journal:  Infect Immun       Date:  2022-09-06       Impact factor: 3.609

5.  Variability in Zinc Concentration among Mueller-Hinton Broth Brands: Impact on Antimicrobial Susceptibility Testing of Metallo-β-Lactamase-Producing Enterobacteriaceae.

Authors:  Anastasia Bilinskaya; Douglas J Buckheit; Michael Gnoinski; Tomefa E Asempa; David P Nicolau
Journal:  J Clin Microbiol       Date:  2020-11-18       Impact factor: 5.948

6.  Cefiderocol: Discovery, Chemistry, and In Vivo Profiles of a Novel Siderophore Cephalosporin.

Authors:  Takafumi Sato; Kenji Yamawaki
Journal:  Clin Infect Dis       Date:  2019-11-13       Impact factor: 9.079

7.  In Vitro Antibacterial Activity of Cefiderocol against Multidrug-Resistant Acinetobacter baumannii.

Authors:  Jacinda C Abdul-Mutakabbir; Logan Nguyen; Philip T Maassen; Kyle C Stamper; Razieh Kebriaei; Keith S Kaye; Mariana Castanheira; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

Review 8.  Iron Acquisition Systems of Gram-negative Bacterial Pathogens Define TonB-Dependent Pathways to Novel Antibiotics.

Authors:  Phillip E Klebba; Salete M C Newton; David A Six; Ashish Kumar; Taihao Yang; Brittany L Nairn; Colton Munger; Somnath Chakravorty
Journal:  Chem Rev       Date:  2021-03-16       Impact factor: 60.622

9.  In Vitro Antibacterial Properties of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacteria.

Authors:  Akinobu Ito; Takafumi Sato; Merime Ota; Miki Takemura; Toru Nishikawa; Shinsuke Toba; Naoki Kohira; Satoshi Miyagawa; Naoki Ishibashi; Shuhei Matsumoto; Rio Nakamura; Masakatsu Tsuji; Yoshinori Yamano
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

10.  Stability and low induction propensity of cefiderocol against chromosomal AmpC β-lactamases of Pseudomonas aeruginosa and Enterobacter cloacae.

Authors:  Akinobu Ito; Toru Nishikawa; Merime Ota; Tsukasa Ito-Horiyama; Naoki Ishibashi; Takafumi Sato; Masakatsu Tsuji; Yoshinori Yamano
Journal:  J Antimicrob Chemother       Date:  2018-11-01       Impact factor: 5.790
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.